-
- Posted Tuesday September 24, 2013
TGen President Dr. Jeffrey Trent is one of state's 'Leaders of the Year'
Arizona Capitol Times recognizes 20 Arizonans for advancing public policy
PHOENIX, Ariz. - Sept. 24, 2013 - Dr.
Jeffrey Trent, President and Research Director of the non-profit
Translational Genomics Research Institute (TGen), is
being recognized today for his leadership in healthcare by the
Arizona Capitol Times.
Dr. Trent was named by the newspaper as one of Arizona's "2013
Leaders of the Year in Public Policy" in the category of
Healthcare, and will be honored at a presentation from 5:30-7:30
p.m. today, Sept. 24, at The Phoenician, 6000 E. Camelback Road,
for "advancing public policy to positively impact the state and the
lives of Arizonans."
"Local medical research benefits local patients first. I am
honored to represent TGen faculty and staff for their extraordinary
work inadvancinghealthcare, especially here in
Arizona," said Dr. Trent. "Key to TGen's success is its
collaboration withArizona's growing biomedical
community."
Dr. Trent is being honored for his work with TGen and the advances
being made across Arizona to research and find therapies for
serious healthcare ailments - such as cancer, diabetes and other
disorders, said Ginger Lamb, vice president and publisher of
Arizona News Service and Arizona Capitol Times.
"Under Dr. Trent's leadership, TGen is on the cutting edge of
research across Arizona and the country. It's hard to believe that
TGen hasn't been part of Arizona for more than 11 years, given all
that it has accomplished and contributed to our state. It truly is
a leader in healthcare research," Lamb said.
Other honorees were selected in education, arts and humanities,
business, economic development, environment, government,
legislative, public safety, social services, technology,
transportation, volunteerism, lifetime achievement, unsung hero,
and (new this year) up and comer. Details: azcapitoltimes.com/events/2013-leaders-of-the-year/
# # #
About TGen
Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. TGen is focused
on helping patients with cancer, neurological disorders and
diabetes, through cutting edge translational research (the process
of rapidly moving research towards patient benefit). TGen
physicians and scientists work to unravel the genetic components of
both common and rare complex diseases in adults and children.
Working with collaborators in the scientific and medical
communities literally worldwide, TGen makes a substantial
contribution to help our patients through efficiency and
effectiveness of the translational process. For more information,
visit:www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
